Highly aggressive pulmonary epithelioid hemangioendothelioma: A case report
DOI:
https://doi.org/10.23938/ASSN.0035Keywords:
Epithelioid hemangioendothelioma. Lung.Abstract
Pulmonary epithelioid hemangioendothelioma is an uncommon neoplastic disease of endothelial origin, with an incidence inferior to one in a million. It usually behaves as a low-grade malignancy; nevertheless, a few cases have been described in which this tumour manifests a highly aggressive behavior, spreading throughout the organism. We report the case of a 77-year-old woman who was diagnosed with metastatic pulmonary epithelioid hemangioendothelioma with severe symptoms, requiring urgent treatment to palliate them.
Downloads
References
DAIL DH, LIEBOW AA. Intravascular bronchioloalveolar tumor. Am J Pathol 1975; 78: 6a-7a.
MENTZEL T, BEHAM A, CALONJE E, KATENKAMP D, FLETCHER CD. Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases. Am J Surg Pathol 1997; 21: 363-374.
YE B, LI W, FENG J, SHI J-X, CHEN Y, HAN B-H. Treatment of pulmonary epithelioid hemangioendothelioma with combination chemotherapy: Report of three cases and review of the literature. Oncol Lett 2013; 5: 1491-1496.
MEHTA SR, DAS A, BARNARD N, MARCUS A. Metastatic pulmonary epithelioid hemangioendothelioma: A case report and review of the literature. Respir Med Case Rep 2012; 7: 17-20.
GAUR S, TORABI A, O’NEILL TJ. Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: A case report. Cancer Biol Med 2012; 9: 133-136.
PROCHILO T, SAVELLI G, BERTOCCHI P, ABENI C, ROTA L, RIZZI A, et al. Targeting VEGF-VEGFR Pathway by sunitinib in peripheral primitive neuroectodermal tumor, paraganglioma and epithelioid hemangioendothelioma: three case reports. Case Rep Oncol 2013; 6: 90-97.
PINET C, MAGNAN A, GARBE L, PAYAN MJ, VERVLOET D. Aggressive form of pleural epithelioid haemangioendothelioma: complete response after chemotherapy. Eur Respir J 1999; 14: 237-238.
GILL R, O'DONNELL RJ, HORVAI A. Utility of immunohistochemistry for endothelial markers in distinguishing epithelioid hemangioendothelioma from carcinoma metastatic to bone. Arch Pathol Lab Med 2009; 133: 967-972.
EMAMAULLEE JA, EDGAR R, TOSO C, THIESEN A, BAIN V, BIGAM D et al. Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: Implications for treatment and surgical management. Liver Transpl 2010; 16: 191-197.
AMIN RM, HIROSHIMA K, KOKUBO T, NISHIKAWA M, NARITA M, KUROKI M et al. Risk factors and independent predictors of survival in patients with pulmonary epithelioid haemangioendothelioma. Review of the literature and a case report. Respirology 2006; 11: 818-825.
BAGAN P, HASSAN M, LE PIMPEC BARTHES F, PEYRARD S, SOUILAMAS R, DANEL C et al. Prognostic factors and surgical indications of pulmonary epithelioid hemangioendothelioma: a review of the literature. Ann Thorac Surg 2006; 82: 2010-2013.
KITAICHI M, NAGAI S, NISHIMURA K, ITOH H, ASAMOTO H, IZUMI T et al. Pulmonary epithelioid haemangioendothelioma in 21 patients, including three with partial spontaneous regression. Eur Respir J 1998; 12: 89-96.
STACHER E, GRUBER-MÖSENBACHER U, HALBWEDL I, DEI TOS AP, CAVAZZA A, PAPOTTI M et al. The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: new potential therapeutic targets? Lung Cancer 2009; 65: 49-55.
EMAMAULLEE JA, EDGAR R, TOSO C, THIESEN A, BAIN V, BIGAM D et al. Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: Implications for treatment and surgical management. Liver Transpl 2010; 16: 191-197.
AGULNIK M, YARBER JL, OKUNO SH, VON MEHREN M, JOVANOVIC BD, BROCKSTEIN BE et al. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol 2013; 24: 257-263.
CHEVREAU C, LE CESNE A, RAY-COQUARD I, ITALIANO A, CIOFFI A, ISAMBERT N et al. Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO). Cancer 2013; 119: 2639-2644.
SEMENISTY V, NARODITSKY I, KEIDAR Z, BAR-SELA G. Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma-a suitable treatment option: case report and review of anti-angiogenic treatment options. BMC Cancer 2015; 15: 402.
BALLY O, TASSY L, RICHIOUD B, DECOUVELAERE AV, BLAY JY, DERBEL O. Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendothelioma. Clin Sarcoma Res 2015; 23; 5: 12.
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Anales del Sistema Sanitario de Navarra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
